Literature DB >> 2210446

Circulating antibodies against human colonic extract enriched with a 40 kDa protein in patients with ulcerative colitis.

F Takahasi1, H S Shah, L S Wise, K M Das.   

Abstract

We have previously described a 40 kDa colonic protein(s) which is specifically recognised by tissue-bound immunoglobulin G obtained from the colon of patients with ulcerative colitis. We now report the presence of circulating antibodies against this antigen using an enzyme-linked immunosorbent assay with a highly enriched preparation of the 40 kDa protein from normal colon extracts. Serum was collected from 79 patients with ulcerative colitis, 36 with Crohn's disease, 16 with specific diarrhoeal syndromes, and from 19 normal subjects. Twenty nine of 79 patients with ulcerative colitis, 21 of 36 with Crohn's disease, and all patients with diarrhoea were symptomatic during the collection of sera. The difference in optical density values between patients with symptomatic ulcerative colitis and each of the other groups, including patients with ulcerative colitis in remission, was highly significant (p less than 0.01). Seventy nine per cent of patients with symptomatic ulcerative colitis had optical density values above the means for all other groups. Fifty five per cent of sera from patients with symptomatic ulcerative colitis had optical densities beyond two SDs of the values for all other groups and only two of 71 sera from non-ulcerative colitis patients (one Crohn's disease and one normal subject) had values in this range. These results show the presence of anti-colon antibodies against the 40 kDa protein(s) in the sera of many patients with symptomatic ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2210446      PMCID: PMC1378660          DOI: 10.1136/gut.31.9.1016

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  13 in total

1.  Circulating immune complexes in inflammatory bowel disease.

Authors:  D P Jewell; I C MacLennan
Journal:  Clin Exp Immunol       Date:  1973-06       Impact factor: 4.330

2.  Immunohistochemical characterization of local immunoglobulin formation in ulcerative colitis.

Authors:  P Brandtzaeg; K Baklien; O Fausa; P S Hoel
Journal:  Gastroenterology       Date:  1974-06       Impact factor: 22.682

3.  Immunological studies in ulcerative colitis. 3. Incidence of antibodies to colon-antigen in ulcerative colitis and other gastro-intestinal diseases.

Authors:  R Lagercrantz; S Hammarström; P Perlmann; B E Gustafsson
Journal:  Clin Exp Immunol       Date:  1966-07       Impact factor: 4.330

4.  Antigen from colon of germfree rats and antibodies in human ulcerative colitis.

Authors:  P Perlmann; S Hammarström; R Lagercrantz; B E Gustafsson
Journal:  Ann N Y Acad Sci       Date:  1965-06-30       Impact factor: 5.691

5.  Immunological studies in ulcerative colitis. VII. Anti-colon antibodies of different immunoglobulin classes.

Authors:  J Zeromski; P Perlmann; R Lagercrantz; S Hammarström; B E Gustafsson
Journal:  Clin Exp Immunol       Date:  1970-10       Impact factor: 4.330

6.  Autoantibodies to insulin receptor spontaneously develop as anti-idiotypes in mice immunized with insulin.

Authors:  Y Shechter; R Maron; D Elias; I R Cohen
Journal:  Science       Date:  1982-04-30       Impact factor: 47.728

7.  Network theory in autoimmunity. In vitro suppression of serum anti-DNA antibody binding to DNA by anti-idiotypic antibody in systemic lupus erythematosus.

Authors:  N I Abdou; H Wall; H B Lindsley; J F Halsey; T Suzuki
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

8.  Correlation between clinical activity of systemic lupus erythematosus and the amounts of DNA in DNA/anti-DNA antibody immune complexes.

Authors:  C Morimoto; H Sano; T Abe; M Homma; A D Steinberg
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

9.  Monoclonal antibodies to the acetylcholine receptor by a normally functioning auto-anti-idiotypic mechanism.

Authors:  W L Cleveland; N H Wassermann; R Sarangarajan; A S Penn; B F Erlanger
Journal:  Nature       Date:  1983 Sep 1-7       Impact factor: 49.962

10.  Naturally occurring anti-idiotypic antibodies in myasthenia gravis patients.

Authors:  D S Dwyer; R J Bradley; C K Urquhart; J F Kearney
Journal:  Nature       Date:  1983 Feb 17-23       Impact factor: 49.962

View more
  17 in total

1.  Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studies.

Authors:  Bing Xia; JBA Crusius; SGM Meuwissen; AS Pe?a
Journal:  World J Gastroenterol       Date:  1998-10       Impact factor: 5.742

2.  Genes differentially regulated by NKX2-3 in B cells between ulcerative colitis and Crohn's disease patients and possible involvement of EGR1.

Authors:  Wei Yu; Zhenwu Lin; John P Hegarty; Xi Chen; Ashley A Kelly; Yunhua Wang; Lisa S Poritz; Walter A Koltun
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

3.  Serum and tissue autoantibodies to colonic epithelium in ulcerative colitis.

Authors:  K M Das
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

4.  Circulating immunoglobulin G1 antibody in patients with ulcerative colitis against the colonic epithelial protein detected by a novel monoclonal antibody.

Authors:  A Dasgupta; A Mandal; K M Das
Journal:  Gut       Date:  1994-12       Impact factor: 23.059

5.  Detection of anti-colon antibodies in inflammatory bowel disease using human cultured colonic cells.

Authors:  J C Lee; A M Cevallos; A Naeem; J E Lennard-Jones; M J Farthing
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

6.  B Cell-Activating Factor as a New Potential Marker in Inflammatory Bowel Disease.

Authors:  Peipei Zhang; Xiaojing Liu; Aili Guo; Jing Xiong; Yu Fu; Kaifang Zou
Journal:  Dig Dis Sci       Date:  2016-04-07       Impact factor: 3.199

7.  Expression of a unique protein on colon cancer cells that reacts with a novel monoclonal antibody and ulcerative colitis serum.

Authors:  T Hassan; Y Kanisawa; S Meyers; A Dasgupta; K M Das
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

8.  Epithelial deposits of immunoglobulin G1 and activated complement colocalise with the M(r) 40 kD putative autoantigen in ulcerative colitis.

Authors:  T S Halstensen; K M Das; P Brandtzaeg
Journal:  Gut       Date:  1993-05       Impact factor: 23.059

9.  Enzyme linked immunosorbent assay (ELISA) and immunoprecipitation studies on anti-goblet cell antibody using a mucin producing cell line in patients with inflammatory bowel disease.

Authors:  T Hibi; M Ohara; K Kobayashi; W R Brown; K Toda; H Takaishi; Y Hosoda; A Hayashi; Y Iwao; M Watanabe
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

10.  Expression of the 40 kD protein in DLD-1 colon cancer cells and the effect of cytokines.

Authors:  K M Das; L Squillante; F Robertson
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.